Literature DB >> 14726950

Conditional gene knock-down by CRE-dependent short interfering RNAs.

Lauriane Fritsch1, Luis A Martinez, Redha Sekhri, Irina Naguibneva, Mathieu Gérard, Marie Vandromme, Laurent Schaeffer, Annick Harel-Bellan.   

Abstract

Short interfering RNAs (siRNAs) are short (21-23 nt) double-stranded RNAs that direct the sequence-specific degradation of corresponding mRNAs, resulting in suppression of gene activity. siRNAs are powerful tools for gene functional analysis in mammals. Chemically synthesized siRNAs permit transient gene repression but preclude inhibition of stable gene products as well as long-term phenotypic analyses. Permanent gene suppression can be achieved by transcribing siRNAs as stem-loop precursors from Pol III promoters. This approach, however, has a major limitation: inhibition cannot be controlled in a time- or tissue-specific manner. Thus, the approach cannot be applied to genes essential for cell survival or cell proliferation. To overcome these limitations, we have designed a CRE-lox-based strategy that allows one to repress gene activity in a time-dependent manner in cells, and in a time- or tissue-dependent manner in animals. Our approach promises to improve dramatically the procedures for functional genetics in mammals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726950      PMCID: PMC1298975          DOI: 10.1038/sj.embor.7400064

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  19 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

Review 3.  RNA interference--2001.

Authors:  P A Sharp
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

4.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.

Authors:  S M Elbashir; J Martinez; A Patkaniowska; W Lendeckel; T Tuschl
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

Authors:  Makoto Miyagishi; Kazunari Taira
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

Review 6.  'Green mice' and their potential usage in biological research.

Authors:  M Ikawa; S Yamada; T Nakanishi; M Okabe
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

7.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

8.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

9.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

10.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

View more
  17 in total

1.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

2.  Control of siRNA expression using the Cre-loxP recombination system.

Authors:  Vivi Kasim; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

3.  Controlled expression of transgenes introduced by in vivo electroporation.

Authors:  Takahiko Matsuda; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

Review 4.  Defining functional gene-circuit interfaces in the mouse nervous system.

Authors:  M E Soden; B B Gore; L S Zweifel
Journal:  Genes Brain Behav       Date:  2013-09-30       Impact factor: 3.449

5.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

6.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 7.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

8.  Microporation is an efficient method for siRNA-induced knockdown of PEX5 in HepG2 cells: evaluation of the transfection efficiency, the PEX5 mRNA and protein levels and induction of peroxisomal deficiency.

Authors:  Barbara Ahlemeyer; Julia-Franziska Vogt; Vera Michel; Petra Hahn-Kohlberger; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2014-09-17       Impact factor: 4.304

9.  A non-specific effect associated with conditional transgene expression based on Cre-loxP strategy in mice.

Authors:  Linghua Qiu; Jaime A Rivera-Pérez; Zuoshang Xu
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

10.  Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases.

Authors:  Sara E Garwick-Coppens; Adam Herman; Scott Q Harper
Journal:  BMC Biotechnol       Date:  2011-11-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.